TNFSF10 and neoplasm: TRAIL enhances macrophage cytotoxicity against cancer cells and high TRAIL expression in the TME is positively correlated with the expression of M1 markers in cancer patients and longer overall survival in cases with high, but not low, tumor macrophage content.